Multifactorial Effects of Vildagliptin Added to Ongoing Metformin Therapy in Patients With Type 2 Diabetes Mellitus

被引：0
|
作者：
Strozik, Agnieszka
Steposz, Arkadiusz
Okopien, Boguslaw
机构：
来源：
DIABETES | 2013年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2624-PO
引用
收藏
页码：A668 / A668
页数：1
相关论文
共 50 条
  • [1] Multifactorial effects of vildagliptin added to ongoing metformin therapy in patients with type 2 diabetes mellitus
    Strozik, Agnieszka
    Steposz, Arkadiusz
    Basiak, Marcin
    Drozdz, Magdalena
    Okopien, Boguslaw
    [J]. PHARMACOLOGICAL REPORTS, 2015, 67 (01) : 24 - 31
  • [2] Multifactorial effects of vildagliptin added to ongoing metformin therapy in patients with type 2 diabetes mellitus
    Agnieszka Strózik
    Arkadiusz Stęposz
    Marcin Basiak
    Magdalena Drożdż
    Bogusław Okopień
    [J]. Pharmacological Reports, 2015, 67 : 24 - 31
  • [3] The efficacy and safety of adding either vildagliptin or glimepiride to ongoing metformin therapy in patients with type 2 diabetes mellitus
    Kim, Gyuri
    Oh, Sewon
    Jin, Sang-Man
    Hur, Kyu Yeon
    Kim, Jae Hyeon
    Lee, Moon-Kyu
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (12) : 1179 - 1186
  • [4] Combination therapy with metformin plus vildagliptin in type 2 diabetes mellitus
    Guarino, Elisa
    Nigi, Laura
    Patti, Aurora
    Fondelli, Cecilia
    Dotta, Francesco
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (09) : 1377 - 1384
  • [5] Improved glycaemic control with vildagliptin added to insulin, with or without metformin, in patients with type 2 diabetes mellitus
    Kothny, W.
    Foley, J.
    Kozlovski, P.
    Shao, Q.
    Gallwitz, B.
    Lukashevich, V.
    [J]. DIABETES OBESITY & METABOLISM, 2013, 15 (03): : 252 - 257
  • [6] Efficacy and safety of sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes
    Raz, Itamar
    Chen, Yu
    Wu, Mei
    Hussain, Shehla
    Kaufman, Keith D.
    Amatruda, John M.
    Langdon, Ronald B.
    Stein, Peter P.
    Alba, Maria
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (02) : 537 - 550
  • [7] The Combination Therapy With Metformin and Vildagliptin Decreases Lymphocytes Count in patients With Type 2 Diabetes Mellitus
    Zografou, Ioanna
    Sampanis, Christos
    Papageorgiou, Athanasios
    Nikolaidou, Barbara
    Doukelis, Panagiotis
    Papadopoulou, Despina
    Doumas, Michael
    Douma, Stella
    [J]. DIABETES, 2012, 61 : A600 - A600
  • [8] Cognitive and Functional Influences of Vildagliptin, a DPP-4 Inhibitor, Added to Ongoing Metformin Therapy in Elderly with Type 2 Diabetes
    Tasci, Ilker
    Naharci, Mehmet Ilkin
    Bozoglu, Ergun
    Safer, Umut
    Aydogdu, Aydogan
    Yilmaz, Basak Filiz
    Yilmaz, Gulay
    Doruk, Huseyin
    [J]. ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2013, 13 (03) : 256 - 263
  • [9] Efficacy and safety of sitagliptin when added to ongoing metformin therapy in patients with type 2 diabetes
    Scott, R.
    Loeys, T.
    Davies, M. J.
    Engel, S. S.
    [J]. DIABETES OBESITY & METABOLISM, 2008, 10 (10): : 959 - 969
  • [10] Efficacy and tolerability of vildagliptin as add-on therapy to metformin in Chinese patients with type 2 diabetes mellitus
    Pan, C.
    Xing, X.
    Han, P.
    Zheng, S.
    Ma, J.
    Liu, J.
    Lv, X.
    Lu, J.
    Bader, G.
    [J]. DIABETES OBESITY & METABOLISM, 2012, 14 (08): : 737 - 744
12345